Call for tenders Supplies
Médicaments utilisés en oncologie
Notice published in French. The AI analysis summarises it for you in your language.
Tenders due closed — 14 September 2026 at 10:00
- Public buyer
- CHIREC
Bruxelles (Auderghem) - Place of performance
- 1160 Bruxelles (Auderghem), Brussels-Capital
not published: buyer's address - Procedure
- Open procedure
Any company may submit a bid. - Publication
- 5 August 2026
- Notice language
- French
AI analysis: go for it or not?
Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.
Unlimited analyses during the 14-day Pro trial, no card needed.
Description
Médicaments utilisés en oncologie
4 lots
- Évérolimus per os sous forme de comprimés oraux (ATC L01EG02)
- Sunitinib per os sous forme de gélules orales (ATC L01EX01)
- Fulvestrant injectable sous forme de seringues préremplies (ATC L02BA03)
- Abiratérone per os sous forme de comprimés oraux (ATC L02BX03)
CPV codes
European codes that classify what the contract is about. They are how we find the tenders for your trade.
33600000
Winning prices for comparable contracts
- A quarter below
- €269,390
- Median
- €449,863
- A quarter above
- €962,736
Amounts awarded (excl. VAT) over the last 3 years for 58 contracts in the same CPV group (3360…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.
Likely competitors: who wins with this buyer in this field
- Viatris BV · 3 contracts won
- Sandoz SA · 3 contracts won
- Fresenius Kabi · 2 contracts won
- Teva Pharma Belgium · 2 contracts won
- Arega Pharma BVBA · 2 contracts won
Partners and subcontractors
Contract too big or too broad for you alone? Bid as a temporary consortium, or offer your services as a subcontractor.
Create your free account to see who is looking for a partner on this contract, and to register.
Companies winning this type of contract in the region
- ACCORD HEALTHCARE · 10 contracts won in 3 years
- Viatris BV SRL · 7 contracts won in 3 years
- Sandoz SA · 7 contracts won in 3 years
- Fresenius Kabi NV/SA · 4 contracts won in 3 years
- AUROBINDO SA · 3 contracts won in 3 years
- Arega Pharma BV · 3 contracts won in 3 years
- Teva Pharma Belgium · 3 contracts won in 3 years
- EG · 2 contracts won in 3 years
Possible partners for a temporary consortium or subcontracting… and competitors worth knowing.
Similar contracts already awarded
| Contract | Winner | Amount |
|---|---|---|
| Fer injectable CHIREC · 7 October 2026 |
Viatris | €432,640 |
| Antitumoraux per os CHIREC · 16 October 2025 |
EG Grindeks Kalceks Belgium |
€120,203 |
| Époétine alfa CHIREC · 1 April 2025 |
Sandoz | €303,318 |
| Ranibizumab CHIREC · 17 January 2025 |
Teva Pharma Belgium | €571,200 |
| Antitumoraux CHIREC · 17 December 2024 |
ACCORD HEALTHCARE AUROBINDO Fresenius Kabi Arega Pharma |
€977,080 |
Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 542117-2026.